These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 34154447)
21. Influence of age on treatment with proton pump inhibitors in patients with laryngopharyngeal reflux disease: a prospective multicenter study. Lee YC; Lee JS; Kim SW; Kwon KH; Eun YG JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1291-5. PubMed ID: 24201320 [TBL] [Abstract][Full Text] [Related]
22. Is Diet Sufficient as Laryngopharyngeal Reflux Treatment? A Cross-Over Observational Study. Lechien JR; Crevier-Buchman L; Distinguin L; Iannella G; Maniaci A; De Marrez LG; Saussez S; Hans S Laryngoscope; 2022 Oct; 132(10):1916-1923. PubMed ID: 34606102 [TBL] [Abstract][Full Text] [Related]
23. A Study of the Diagnostic Value of the Sign and Symptom Questionnaires for Laryngopharyngeal Reflux Disease. Zhang C; Liu Z; Liu L; Li J; Wang X; Ju J; Wang J; Zhao J; Yu L Otolaryngol Head Neck Surg; 2024 Feb; 170(2):474-479. PubMed ID: 37822126 [TBL] [Abstract][Full Text] [Related]
24. Laryngopharyngeal Reflux Patient Changes during the COVID-19 Quarantine. Rodriguez A; Steffens Y; Calvo-Henriquez C; Mayo-Yáñez M; Horoi M; Lechien JR Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629765 [No Abstract] [Full Text] [Related]
25. Gender differences in the presentation of dysphonia related to laryngopharyngeal reflux disease: a case-control study. Lechien JR; Huet K; Khalife M; Fourneau AF; Finck C; Delvaux V; Piccaluga M; Harmegnies B; Saussez S Eur Arch Otorhinolaryngol; 2018 Jun; 275(6):1513-1524. PubMed ID: 29582172 [TBL] [Abstract][Full Text] [Related]
26. Impact of age on laryngopharyngeal reflux disease presentation: a multi-center prospective study. Lechien JR; Finck C; Huet K; Khalife M; Fourneau AF; Delvaux V; Piccaluga M; Harmegnies B; Saussez S Eur Arch Otorhinolaryngol; 2017 Oct; 274(10):3687-3696. PubMed ID: 28717979 [TBL] [Abstract][Full Text] [Related]
27. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? de Bortoli N; Nacci A; Savarino E; Martinucci I; Bellini M; Fattori B; Ceccarelli L; Costa F; Mumolo MG; Ricchiuti A; Savarino V; Berrettini S; Marchi S World J Gastroenterol; 2012 Aug; 18(32):4363-70. PubMed ID: 22969200 [TBL] [Abstract][Full Text] [Related]
28. Saliva pepsin level of laryngopharyngeal reflux patients is not correlated with reflux episodes. Bobin F; Journe F; Lechien JR Laryngoscope; 2020 May; 130(5):1278-1281. PubMed ID: 31461170 [TBL] [Abstract][Full Text] [Related]
29. Effects of Proton Pump Inhibitor Therapy for Laryngopharyngeal Reflux on Posttreatment Symptoms and Hypopharyngeal pH. Waxman J; Yalamanchali S; Valle ES; Pott T; Friedman M Otolaryngol Head Neck Surg; 2014 Jun; 150(6):1010-7. PubMed ID: 24647643 [TBL] [Abstract][Full Text] [Related]
30. Diagnostic Value of Pepsin Measurements in Dysphonia Attributed to Laryngopharyngeal Reflux Disease. Lechien JR; Hamdan AL J Voice; 2023 Aug; ():. PubMed ID: 37625902 [TBL] [Abstract][Full Text] [Related]
31. Validity and Reliability of the Reflux Sign Assessment-10 (RSA-10). Lechien JR; De Marrez LG; Finck C; Saussez S Laryngoscope; 2024 Sep; 134(9):3981-3988. PubMed ID: 38551328 [TBL] [Abstract][Full Text] [Related]
32. A study with pharyngeal and esophageal 24-hour pH-impedance monitoring in patients with laryngopharyngeal symptoms refractory to proton pump inhibitors. Dulery C; Lechot A; Roman S; Bastier PL; Stoll D; de Gabory L; Zerbib F Neurogastroenterol Motil; 2017 Jan; 29(1):. PubMed ID: 27424517 [TBL] [Abstract][Full Text] [Related]
33. The reflux symptom score has good screening value for laryngopharyngeal reflux. Guo W; Zhang J; Yue H; Lyu K; Chen S; Huang B; Wang Y; Lei W BMC Gastroenterol; 2024 Oct; 24(1):346. PubMed ID: 39363158 [TBL] [Abstract][Full Text] [Related]
34. Changes in Pharyngeal Baseline Impedance in Patients With Laryngopharyngeal Reflux. Doo JG; Kim SI; Park JM; Kwon OE; Lee YC; Eun YG Otolaryngol Head Neck Surg; 2020 Sep; 163(3):563-568. PubMed ID: 32396492 [TBL] [Abstract][Full Text] [Related]
36. Association between 24-hour combined multichannel intraluminal impedance-pH monitoring and symptoms or quality of life in patients with laryngopharyngeal reflux. Kim SI; Kwon OE; Na SY; Lee YC; Park JM; Eun YG Clin Otolaryngol; 2017 Jun; 42(3):584-591. PubMed ID: 28004504 [TBL] [Abstract][Full Text] [Related]
37. Rethinking the laryngopharyngeal reflux treatment algorithm: Evaluating an alternate empiric dosing regimen and considering up-front, pH-impedance, and manometry testing to minimize cost in treating suspect laryngopharyngeal reflux disease. Carroll TL; Werner A; Nahikian K; Dezube A; Roth DF Laryngoscope; 2017 Oct; 127 Suppl 6():S1-S13. PubMed ID: 28842999 [TBL] [Abstract][Full Text] [Related]
38. Change of signs, symptoms and voice quality evaluations throughout a 3- to 6-month empirical treatment for laryngopharyngeal reflux disease. Lechien JR; Finck C; Khalife M; Huet K; Delvaux V; Picalugga M; Harmegnies B; Saussez S Clin Otolaryngol; 2018 Oct; 43(5):1273-1282. PubMed ID: 29768736 [TBL] [Abstract][Full Text] [Related]
39. Dual pH with Multichannel Intraluminal Impedance Testing in the Evaluation of Subjective Laryngopharyngeal Reflux Symptoms. Cumpston EC; Blumin JH; Bock JM Otolaryngol Head Neck Surg; 2016 Dec; 155(6):1014-1020. PubMed ID: 27554506 [TBL] [Abstract][Full Text] [Related]
40. Prevalence of Laryngopharyngeal Reflux Related Symptoms in Patients With Allergy. Hamdan AL; Abi Zeid Daou C; Nawfal N; Lechien JR J Voice; 2024 May; 38(3):754-759. PubMed ID: 35168866 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]